FDA Drug recall D-1025-2018
Doxycycline Hyclate Tablets, USP, 100 mg*. 500-count bottle, Rx only
- FDA Drug
- Class II
- terminated
- Published 2018-08-08
On 2018-08-08 the FDA classified a Class II recall of Doxycycline Hyclate Tablets, USP, 100 mg*. 500-count bottle, Rx only by West Ward Columbus, citing failed Dissolution Specifications:.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1025-2018 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2018-07-24 |
| Published | 2018-08-08 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | West Ward Columbus |
| Distribution | US |
Product
Doxycycline Hyclate Tablets, USP, 100 mg*. 500-count bottle, Rx only. Manufactured by: West-Ward Pharmaceuticals Corp. Eatontown, NJ 07724. NDC# 0143-2112-05.
Reason
Failed Dissolution Specifications:
Identifiers
| ndc | 0143-2112-50 |
|---|---|
| ndc | 0143-2112-05 |
| ndc | 0143-2112-20 |
| code_info | Lot# 71545A, Expiry date: 07/19 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1025-2018%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.